<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00861237</url>
  </required_header>
  <id_info>
    <org_study_id>2342</org_study_id>
    <nct_id>NCT00861237</nct_id>
  </id_info>
  <brief_title>Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery</brief_title>
  <official_title>Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are
      randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under
      double blind conditions. Postoperatively, ECGs are done to monitor cardiac rhythm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then,
      patients are observed regarding atrial fibrillation postsurgical. The difference between the
      group of patients with and without nux vomica is recorded.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Number of patients recruited to small, no cooperation of study members
  </why_stopped>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of atrial fibrillation after heart surgery with heart lung machine</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Placebo globules group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nux vomica group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive Nux vomica globules made out of sugar sublingually before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nux vomica (active comparator)</intervention_name>
    <description>Patients receive Nux vomica in a homeopathic potentiation</description>
    <arm_group_label>Nux vomica group</arm_group_label>
    <other_name>Strychnos Nux vomica C200</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (placebo comparator)</intervention_name>
    <description>Patients receive Placebo looking similar to active drug</description>
    <arm_group_label>Placebo globules group</arm_group_label>
    <other_name>Placebo globules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients before elective Heart valve - or aortocoronary by pass surgery with
             heart-lung-machine.

        Exclusion Criteria:

          -  Pregnant patients

          -  Patients with preoperative atrial fibrillation and/or hyperthyreosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Frass, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Surgery, Med Univ Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>A1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2009</study_first_submitted>
  <study_first_submitted_qc>March 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2009</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Michael Frass</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Nux vomica</keyword>
  <keyword>homeopathy</keyword>
  <keyword>heart lung machine</keyword>
  <keyword>heart surgery</keyword>
  <keyword>postoperatively studied</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

